MADISON, N.J., May 15, 2015 /PRNewswire/ -- Quest Diagnostics DGX, the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share, payable on July 22, 2015 to shareholders of record of Quest Diagnostics common stock on July 8, 2015.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Quest Diagnostics Contacts:
Dan Haemmerle (Investors): 973-520-2900
Denny Moynihan (Media): 973-520-2800
Logo - http://photos.prnewswire.com/prnh/20150422/200883LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-300084093.html
SOURCE Quest Diagnostics
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.